1. Early infection risk in patients with systemic lupus erythematosus treated with rituximab or belimumab from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR): a prospective longitudinal study. (May 2023) Authors: Rodziewicz, Mia; Dyball, Sarah; Lunt, Mark; McDonald, Stephen; Sutton, Emily; Parker, Ben; Bruce, Ian N; Abernethy, Rikki; Ahmad, Yasmeen; Akil, Mohamed; Bartram, Sarah; Batley, Mike; Bharadwaj, Anurag; Bruce, Ian; Carlucci, Francesco; Chan, Antoni; Dasgupta, Bhaskar; D'Cruz, David; De Lord, Deni... Journal: Lancet Issue: Volume 5:Number 5(2023) Page Start: e284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗